1. Home
  2. TWST vs BUSE Comparison

TWST vs BUSE Comparison

Compare TWST & BUSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TWST
  • BUSE
  • Stock Information
  • Founded
  • TWST 2013
  • BUSE 1868
  • Country
  • TWST United States
  • BUSE United States
  • Employees
  • TWST N/A
  • BUSE N/A
  • Industry
  • TWST Biotechnology: Biological Products (No Diagnostic Substances)
  • BUSE Major Banks
  • Sector
  • TWST Health Care
  • BUSE Finance
  • Exchange
  • TWST Nasdaq
  • BUSE Nasdaq
  • Market Cap
  • TWST 2.3B
  • BUSE 2.0B
  • IPO Year
  • TWST 2018
  • BUSE N/A
  • Fundamental
  • Price
  • TWST $25.76
  • BUSE $24.68
  • Analyst Decision
  • TWST Buy
  • BUSE Buy
  • Analyst Count
  • TWST 9
  • BUSE 7
  • Target Price
  • TWST $50.67
  • BUSE $27.43
  • AVG Volume (30 Days)
  • TWST 1.6M
  • BUSE 451.6K
  • Earning Date
  • TWST 08-04-2025
  • BUSE 10-21-2025
  • Dividend Yield
  • TWST N/A
  • BUSE 4.04%
  • EPS Growth
  • TWST N/A
  • BUSE N/A
  • EPS
  • TWST N/A
  • BUSE 1.13
  • Revenue
  • TWST $362,273,000.00
  • BUSE $498,525,000.00
  • Revenue This Year
  • TWST $22.28
  • BUSE $62.58
  • Revenue Next Year
  • TWST $17.40
  • BUSE $11.62
  • P/E Ratio
  • TWST N/A
  • BUSE $21.95
  • Revenue Growth
  • TWST 22.72
  • BUSE 16.77
  • 52 Week Low
  • TWST $24.28
  • BUSE $18.40
  • 52 Week High
  • TWST $55.33
  • BUSE $28.30
  • Technical
  • Relative Strength Index (RSI)
  • TWST 36.12
  • BUSE 64.16
  • Support Level
  • TWST $24.97
  • BUSE $24.12
  • Resistance Level
  • TWST $27.29
  • BUSE $24.78
  • Average True Range (ATR)
  • TWST 1.23
  • BUSE 0.49
  • MACD
  • TWST 0.10
  • BUSE 0.11
  • Stochastic Oscillator
  • TWST 20.73
  • BUSE 77.78

About TWST Twist Bioscience Corporation

Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States.

About BUSE First Busey Corporation

First Busey Corporation is a financial holding company, whose subsidiaries provides retail and commercial banking services, remittance processing, and offers financial products and services with banking centers in Illinois, Missouri, Florida, and Indiana. The company's operations are managed through three operating segments consisting of Banking, FirsTech and Wealth Management. The banking segment generates a vast majority of its revenue.

Share on Social Networks: